Menu
Are you a plan sponsor or advisor? Do your plan members have claims for specialty drugs? If so, it’s likely that plan members have questions regarding the prior authorization process, a process common for the reimbursement of specialty drugs
Read our new article in the May edition of the Benefits and Pension Monitor magazine, where we explore the history of prior authorization, specialty drug spend, new technologies and solutions to advance prior authorization.
Do you or your clients have specialty drug claims on group benefit plans? If so, you need to read this blog and find out about the new patient information and resources website.
The Simplify Prior Authorization (SPA) initiative recently hosted its first webinar in 2023 for group benefits stakeholders on new prior authorization (PA) resources and solutions. Interest was high, with the largest registration numbers since the initiative began.
On April 19th and May 3rd, 2022, the Simplify Prior Authorization (SPA) initiative hosted webinars for patient groups and advisors/plan sponsors on the Challenges and New Solutions in the Private Prior Authorization Landscape.
Canadians with cancer have been experiencing longer times to diagnosis and medical treatment during the pandemic. A backlog has been building that will take years to address, according to Dr Tony Eskander, surgical oncologist of the mouth, throat and neck at Sunnybrook Health Sciences Centre in Toronto.
The Simplify Prior Authorization initiative is an advocate for education about prior authorization (PA) and improvement in current prior authorization practices and processes. If your organization is interested in finding out more, getting involved, or in sponsorship of this important initiative, please contact us via the link below.
